MAIA Biotechnology Inc. (MAIA)

US · Healthcare · Biotechnology

$1.10-1.79%

Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue

Net profit

$-7.9M

EPS

$-0.13

EPS estimate

$-0.11

EPS came in at -0.13 against a street estimate of -0.11 — a miss of 18.2%.

Market cap

$75.3M

Forward P/E

0.0

P/B

3.88

Book value

$0.34

EPS (TTM)

$-0.62

52-week high

$3.19

52-week low

$0.87

50-day MA

$1.32

200-day MA

$1.49

Beta

0.28

Analysts rate MAIA Biotechnology Inc. a strong buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $12.00.

Insiders

14.41%

Institutions

21.91%

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for MAIA Biotechnology Inc. — free to start.

Data updated 2026-10-18.